Trade LBRX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
LB Pharmaceuticals Inc (LBRX) is trading at US$36.74, up 0.14% today as of Oct 16, 16:00 EDT. The company has a market capitalisation of US$1.54B. Over the past 52 weeks, LBRX has traded between US$14.32 and US$50.16. On Syfe you can trade LBRX with $0 commission and add it to your watchlist.
| Previous close | US$36.69 |
|---|---|
| Market cap | US$1.54B |
| 52-week range | US$14.32 – US$50.16 |
| Volume | 724.73K |
| Exchange | US |
LB Pharmaceuticals Inc
LB Pharmaceuticals, Inc. engages in the research and development of novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its product pipeline includes LB-102, is a Phase 3-ready oral, small molecule for the treatment of acute schizophrenia, defined as a sudden and severe episode of psychotic symptoms, characterized by hallucinations, delusions, and other positive symptoms. The company was founded by Vince Grattan and Zachary Prensky in 2015 and is headquartered in New York.
Year: 2025
LB Pharmaceuticals Names Joseph Miller CFO
Sep 3, 12:38 PM · MT Newswires
LB Pharmaceuticals Q2 Loss Per Share Narrows
Aug 11, 12:40 PM · MT Newswires
LB Pharmaceuticals Inc (LBRX) stock is trading at US$36.74, +0.14% from the previous close of US$36.69.
The market cap for LB Pharmaceuticals Inc (LBRX) stock is approximately US$1.54B.
The 52-week high for LB Pharmaceuticals Inc (LBRX) stock is US$50.16.
The 52-week low for LB Pharmaceuticals Inc (LBRX) stock is US$14.32.
LB Pharmaceuticals Inc (LBRX) does not currently pay a dividend.
Stay on top of LBRX
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
